Use of Recombinant Factor VIIa to Facilitate Organ Donation in Trauma Patients with Devastating Neurologic Injury

Journal of the American College of Surgeons

Volumn 208, Issue 1, 2009, Pages 120-125

  Stein, Deborah M ^a   Dutton, Richard P ^a   Alexander, Charlie ^b   Miller, John ^b   Scalea, Thomas M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Living Legacy Foundation of Maryland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN DEATH; CONTROLLED STUDY; FEMALE; HUMAN; INJURY SCALE; LUNG; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ORGAN DONOR; PRIORITY JOURNAL; SALVAGE THERAPY; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; BRAIN INJURIES; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR VIIA; FEMALE; HEMORRHAGE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TISSUE AND ORGAN PROCUREMENT; YOUNG ADULT;

EID: 57749192289     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2008.09.027     Document Type: Article

References (49)

1. Understanding donation: Statistics. http://www.donatelife.net/UnderstandingDonation/Statistics.php Accessed June 11, 2008
2. Shafer T.J., Wagner D., Chessare J., et al. Donation Breakthrough Collaborative: increasing organ donation through system redesign. Crit Care Nurse 26 (2006) 35-49
3. Jenkins D.H., Reilly P.M., and Schwab C.W. Improving the approach to organ donation: a review. World J Surg 23 (1999) 644-649
4. Salim A., Martin M., Brown C., et al. Complications of brain death: frequency and impact on organ retrieval. Am Surg 72 (2006) 377-381
5. Salim A., Martin M., Brown C., et al. The effect of a protocol of aggressive donor management: implications for the national organ donor shortage. J Trauma 61 (2006) 429-435
6. Gore S.M., Ross Taylor R.M., and Wallwork J. Availability of transplantable organs from brain stem donors in intensive care units. BMJ 302 (1991) 149-153
7. Deceased donors recovered in the US by cause of death. http://www.optn.org/latestData/rptData.asp Accessed June 22, 2008
8. Cortiana M., Zagara G., Fava S., and Seveso M. Coagulation abnormalities in patients with head injury. J Neurosurg 30 (1986) 133-138
9. Valdivia M., Chamorro C., Romera M.A., et al. Effect of posttraumatic donor's disseminated intravascular coagulation in intrathoracic organ donation and transplantation. Transplant Proc 39 (2007) 2427-2428
10. Zygun D.A., Kortbeek J.B., Fick G.H., et al. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med 33 (2005) 654-660
11. Hulka F., Mullins R., and Frank E. Blunt brain injury activates the coagulation process. Arch Surg 131 (1996) 923-928
12. Stein S.C., and Smith D.H. Coagulopathy in traumatic brain injury. Neurocrit Care 1 (2004) 479-488
13. Power B.M., and Van Heerden P.V. The physiological changes associated with brain death-Current concepts and implications for treatment of the brain dead organ donor. Anaesth Intensive Care 23 (1995) 26-36
14. Croezen D.H., and Van Natta T.L. Presentation and outcomes for organ donation in patients with cerebral gunshot wounds. Clin Transplant 15 (2001) 11-15
15. Powner D.J., Hartwell E.A., and Hoots W.K. Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery 57 (2005) 823-831
16. Hedner U. Mechanism of action of factor VIIa in the treatment of coagulopathies. Semin Thromb Hemost 32 Suppl (2006) S77-S85
17. Kenet G., Walden R., Eldad A., and Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354 (1999) 1879
18. Dutton R.P., McCunn M., Hyder M., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 57 (2004) 709-719
19. Harrison T.D., Laskosky J., Jazaeri O., et al. "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 59 (2005) 150-154
20. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-15
21. Rizoli S.B., Nascimento B., Osman F., et al. Recombinant activated coagulation factor VII and bleeding trauma patients. J Trauma 61 (2006) 1419-1425
22. Perkins J.G., Schreiber M.A., Wade C.E., and Holcomb J.B. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. J Trauma 62 (2007) 1095-1101
23. Sørensen B., Johansen P., Nielsen G.L., et al. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coag Fibrin 14 (2003) 469-477
24. Roitberg B., Emechebe-Kennedy O., Amin-Hanjani S., et al. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery 57 (2005) 832-836
25. Park P., Fewel M.E., Garton H.J., et al. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery 53 (2003) 34-39
26. Karadimov D., Binev K., Nachkov Y., and Platikanov V. Use of activated recombinant factor VII (Novoseven) during neurosurgery. J Neurosurg Anesthesiol 15 (2003) 330-332
27. Yusim Y., Perel A., Berkenstadt H., et al. The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications. J Clin Anesth 18 (2006) 545-551
28. Freeman W.D., Brott T.G., Barrett K.M., et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 79 (2004) 1495-5000
29. Lin J., Hanigan W.C., Tarantino M., et al. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 98 (2003) 737-740
30. Brody D.L., Aiyagari V., Shackleford A.M., and Diringer M.N. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2 (2005) 263-267
31. Stein D.M., Dutton R.P., Kramer M.E., et al. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. J Trauma 64 (2008) 620-628
32. Levy J.H., Fingerhut A., Brott T., et al. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 46 (2006) 919-933
33. Tawil I., Stein D.M., Mirvis S.E., and Scalea T.M. Post traumatic cerebral infarction: incidence, outcome, and risk factors. J Trauma 64 (2008) 849-853
34. Thomas G.O., Dutton R.P., Hemlock B., et al. Thromboembolic complications associated with factor VIIa administration. J Trauma 62 (2007) 564-569
35. Siegel L.J., Gerigk L., Tuettenberg J., et al. Cerebral sinus thrombosis in a trauma patient after recombinant activated factor VII infusion. Anesthesiology 100 (2004) 441-443
36. O'Connell N.M., Perry D.J., Hodgson A.J., et al. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 43 (2003) 1711-1716
37. Brain Trauma Foundation and AANS/CNS Joint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 24 Suppl (2007) S1-S106
38. White C.E., Schrank A.E., Baskin T.W., and Holcomb J.B. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage. Curr Surg 63 (2006) 310-317
39. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 777-785
40. May A.K., Young J.S., Butler K., et al. Coagulopathy in severe closed head injury: is empiric therapy warranted?. Am Surg 63 (1997) 233-237
41. Aiyagari V., Menendez J.A., and Diringer M.N. Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII. J Crit Care 20 (2005) 176-179
42. Pavese P., Bonadona A., Beaubien J., et al. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth 52 (2005) 26-29
43. Meijer K., Hendriks H.G., De Wolf J.T., et al. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 14 (2003) 169-174
44. Dunkley S.M., and Mackie F. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent. Hematology 8 (2003) 263-264
45. Pugliese F., Ruberto F., Summonti D., et al. Activated recombinant factor VII in orthotopic liver transplantation. Transplant Proc 39 (2007) 1883-1885
46. Hendriks H.G., Meijer K., de Wolf J.T., et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation a pilot study. Transplantation 71 (2001) 402-405
47. De G., Baudo F., and De Carlis L. Recombinant FVII in orthotopic liver transplantation (OLT), a preliminary single-centre experience. Intensive Care Med 31 (2005) 315-316
48. Lisman T., Leebeek F.W., and Meijer K. Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation. Hepatology 35 (2002) 616-621
49. Schreiber M.A., Holcomb J.B., Hedner U., et al. The effect of recombinant factor VIIa on noncoagulopathic pigs with grade V liver injuries. J Am Coll Surg 196 (2003) 691-697